Trial intelligence / Profile preview

Immune Response to VZV Vaccine in Kenyan Women

NCT02514018Phase 4Unknown

Sponsor
University of Toronto
Start
Sep 2015
Primary completion
Jan 2017
Modality
Live Attenuated Vaccines
Countries
1
01

Overview

A Phase 4 trial of zoster vaccine, live in herpes zoster (HZ), sponsored by University of Toronto. Status: unknown.

02

Drugs

zoster vaccine, live
03

Conditions

herpes zoster (HZ)

Beyond the preview

Go deeper on NCT02514018.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02514018.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call